A novel RANKL‐targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species

A novel RANKL‐targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species

Abstract Background and purpose Osteoporosis is characterized by excessive bone resorption due to enhanced osteoclast activation. Stimulation of nuclear factor of activated T cells 1 (NFATc1) and accumulation of reactive oxygen species (ROS) are important mechanisms underlying osteoclastogenesis. Ro...

Full description

Bibliographic Details
Main Authors:	Guoju Hong, Zhenqiu Chen, Xiaorui Han, Lin Zhou, Fengxiang Pang, Rishana Wu, Yingshan Shen, Xiaoming He, Zhinan Hong, Ziqi Li, Wei He, Qiushi Wei
Format:	Article
Language:	English
Published:	Wiley 2021-05-01
Series:	Clinical and Translational Medicine
Subjects:	NFAcT1 osteoclast osteoporosis RANKL Robinin ROS
Online Access:	https://doi.org/10.1002/ctm2.392

Similar Items

Asiatic Acid Inhibits OVX-Induced Osteoporosis and Osteoclastogenesis Via Regulating RANKL-Mediated NF-κb and Nfatc1 Signaling Pathways
by: Guoju Hong, et al.
Published: (2020-03-01)

The Effects of Aronia melanocarpa ‘Viking’ Extracts in Attenuating RANKL-Induced Osteoclastic Differentiation by Inhibiting ROS Generation and c-FOS/NFATc1 Signaling
by: Mithun Ghosh, et al.
Published: (2018-03-01)

Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT
by: Guoju Hong, et al.
Published: (2017-01-01)

LAMP-2 Is Involved in Surface Expression of RANKL of Osteoblasts In Vitro
by: Ineke D.C. Jansen, et al.
Published: (2020-08-01)

(−)-Epicatechin 3-O-β-d-allopyranoside prevent ovariectomy-induced bone loss in mice by suppressing RANKL-induced NF-κB and NFATc-1 signaling pathways
by: Hung-Bo Hsiao, et al.
Published: (2017-05-01)

Osteoclast activity in osteoporosis mandibular bone based on RANKL and osteoprotegerin ratio.
by: Mefina Kuntjoro, et al.
Published: (2021-11-01)

Aspirin inhibits RANKL-induced osteoclast differentiation in dendritic cells by suppressing NF-κB and NFATc1 activation
by: Lili Wu, et al.
Published: (2019-12-01)

Niclosamide and its derivative DK‐520 inhibit RANKL‐induced osteoclastogenesis
by: Yurui Jiao, et al.
Published: (2020-08-01)

The participation of RANK, RANKL and OPG in tumor osteolysis
by: Marcin Stanisławowski, et al.
Published: (2009-05-01)

Zoledronate Enhances Osteocyte-Mediated Osteoclast Differentiation by IL-6/RANKL Axis
by: Hyung Joon Kim, et al.
Published: (2019-03-01)

Chaenomelis fructus inhibits osteoclast differentiation by suppressing NFATc1 expression and prevents ovariectomy-induced osteoporosis
by: Minsun Kim, et al.
Published: (2020-02-01)

Piceatannol attenuates RANKL-induced osteoclast differentiation and bone resorption by suppressing MAPK, NF-κB and AKT signalling pathways and promotes Caspase3-mediated apoptosis of mature osteoclasts
by: Liuliu Yan, et al.
Published: (2019-06-01)

Necrostatin－7 suppresses RANK－NFATc1 signaling and attenuates macrophage to osteoclast differentiation
by: Fuji, Hiroaki
Published: (2019)

Sitagliptin, An Anti-diabetic Drug, Suppresses Estrogen Deficiency-Induced OsteoporosisIn Vivo and Inhibits RANKL-Induced Osteoclast Formation and Bone Resorption In Vitro
by: Chuandong Wang, et al.
Published: (2017-06-01)

Maternal RANKL Reduces the Osteopetrotic Phenotype of Null Mutant Mouse Pups
by: Benjamin Navet, et al.
Published: (2018-11-01)

Effect of TNF-α on osteocyte RANKL expression during orthodontic tooth movement
by: Aseel Marahleh, et al.
Published: (2021-10-01)

Bioflavonoid Robinin from <i>Astragalus falcatus</i> Lam. Mildly Improves the Effect of Metothrexate in Rats with Adjuvant Arthritis
by: Lia Tsiklauri, et al.
Published: (2021-04-01)

Substance P participates in periodontitis by upregulating HIF-1α and RANKL/OPG ratio
by: Kaixian Yan, et al.
Published: (2020-01-01)

Betulin Suppresses Osteoclast Formation via Down-Regulating NFATc1
by: Kwang-Jin Kim, et al.
Published: (2018-06-01)

The RANKL expression and osteoclast in alveolar bone of rat diabetic model at different mechanical force application
by: Nuzulul Hikmah, et al.
Published: (2018-03-01)

Dual Oxidase Maturation Factor 1 Positively Regulates RANKL-Induced Osteoclastogenesis via Activating Reactive Oxygen Species and TRAF6-Mediated Signaling
by: Yoon-Hee Cheon, et al.
Published: (2020-09-01)

Activation of Shc1 Allows Oncostatin M to Induce RANKL and Osteoclast Formation More Effectively Than Leukemia Inhibitory Factor
by: Emma Persson, et al.
Published: (2019-05-01)

Carbon Monoxide Inhibits Receptor Activator of NF-κB (RANKL)-Induced Osteoclastogenesis
by: Feng-Jen Tseng, et al.
Published: (2015-07-01)

Berberine Sulfate Attenuates Osteoclast Differentiation through RANKL Induced NF-κB and NFAT Pathways
by: Lin Zhou, et al.
Published: (2015-11-01)

Norlichexanthone purified from plant endophyte prevents postmenopausal osteoporosis by targeting ERα to inhibit RANKL signaling
by: Keqi Wang, et al.
Published: (2021-02-01)

Macrophages Switch to an Osteo‐Modulatory Profile Upon RANKL Induction in a Medaka (Oryzias latipes) Osteoporosis Model
by: Quang Tien Phan, et al.
Published: (2020-11-01)

Daily chemical evodiamine from Chinese prickly ash attenuates osteoclast differentiation through RANKL induced NFAT pathways
by: Lei Jiang, et al.
Published: (2017-10-01)

Inhibitory Effect of Cudratrixanthone U on RANKL-Induced Osteoclast Differentiation and Function in Macrophages and BMM Cells
by: Eun-Nam Kim, et al.
Published: (2020-08-01)

(−)-Epigallocatechin-3-Gallate Decreases Osteoclastogenesis via Modulation of RANKL and Osteoprotegrin
by: Shih-Tse Chen, et al.
Published: (2019-01-01)

Placotylene A, an Inhibitor of the Receptor Activator of Nuclear Factor-κB Ligand-Induced Osteoclast Differentiation, from a Korean Sponge Placospongia sp.
by: Hiyoung Kim, et al.
Published: (2014-04-01)

TNFα Increases RANKL Expression via PGE2-Induced Activation of NFATc1
by: Hyun-Jung Park, et al.
Published: (2017-02-01)

Guizhi-Shaoyao-Zhimu decoction attenuates bone erosion in rats that have collagen-induced arthritis via modulating NF‐κB signalling to suppress osteoclastogenesis
by: Shu-jun Wei, et al.
Published: (2021-01-01)

Nrf2 is required for suppressing osteoclast RANKL-induced differentiation in RAW 264.7 cells via inactivating cannabinoid receptor type 2 with AM630
by: Wan Li, et al.
Published: (2020-06-01)

Inhibitory Effects of Rhaponticin on Osteoclast Formation and Resorption by Targeting RANKL-Induced NFATc1 and ROS Activity
by: Jianbo He, et al.
Published: (2021-09-01)

Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR
by: Jiachao Guo, et al.
Published: (2017-10-01)

Corrigendum: Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR
by: Jiachao Guo, et al.
Published: (2018-01-01)

Protective Effects of Fermented Oyster Extract against RANKL-Induced Osteoclastogenesis through Scavenging ROS Generation in RAW 264.7 Cells
by: Jin-Woo Jeong, et al.
Published: (2019-03-01)

Ethanol Extract of Atractylodes macrocephala Protects Bone Loss by Inhibiting Osteoclast Differentiation
by: Youn-Hwan Hwang, et al.
Published: (2013-06-01)

Water Extract of Acer tegmentosum Reduces Bone Destruction by Inhibiting Osteoclast Differentiation and Function
by: Hyunil Ha, et al.
Published: (2014-04-01)

Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases
by: Alexander Upfill‐Brown, et al.
Published: (2019-10-01)